Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EMPAGLIFLOZIN Cause Full blood count abnormal? 58 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 58 reports of Full blood count abnormal have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.2% of all adverse event reports for EMPAGLIFLOZIN.

58
Reports of Full blood count abnormal with EMPAGLIFLOZIN
0.2%
of all EMPAGLIFLOZIN reports
0
Deaths
11
Hospitalizations

How Dangerous Is Full blood count abnormal From EMPAGLIFLOZIN?

Of the 58 reports, 11 (19.0%) required hospitalization.

Is Full blood count abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 58 reports have been filed with the FAERS database.

What Other Side Effects Does EMPAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,644) Fungal infection (1,941) Blood glucose increased (1,797) Euglycaemic diabetic ketoacidosis (1,769) Weight decreased (1,661) Urinary tract infection (1,439) Ketoacidosis (1,411) Dizziness (1,372) Nausea (1,333) Vomiting (1,201)

What Other Drugs Cause Full blood count abnormal?

ALBUTEROL (3,060) PREDNISONE (2,230) BUDESONIDE\FORMOTEROL (1,786) TIOTROPIUM (1,754) MONTELUKAST (1,529) MEPOLIZUMAB (1,440) BUDESONIDE (1,339) PALBOCICLIB (1,146) CICLESONIDE (916) PANTOPRAZOLE (776)

Which EMPAGLIFLOZIN Alternatives Have Lower Full blood count abnormal Risk?

EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN EMPAGLIFLOZIN vs EMSAM EMPAGLIFLOZIN vs EMTRICITABINE

Related Pages

EMPAGLIFLOZIN Full Profile All Full blood count abnormal Reports All Drugs Causing Full blood count abnormal EMPAGLIFLOZIN Demographics